BE831654A - Nouveaux derives de quinazoline et medicament les contenant - Google Patents

Nouveaux derives de quinazoline et medicament les contenant

Info

Publication number
BE831654A
BE831654A BE158540A BE158540A BE831654A BE 831654 A BE831654 A BE 831654A BE 158540 A BE158540 A BE 158540A BE 158540 A BE158540 A BE 158540A BE 831654 A BE831654 A BE 831654A
Authority
BE
Belgium
Prior art keywords
emi
group
lower alkyl
compound according
radical
Prior art date
Application number
BE158540A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE831654A publication Critical patent/BE831654A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE158540A 1974-07-25 1975-07-23 Nouveaux derives de quinazoline et medicament les contenant BE831654A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25

Publications (1)

Publication Number Publication Date
BE831654A true BE831654A (fr) 1976-01-23

Family

ID=10344259

Family Applications (1)

Application Number Title Priority Date Filing Date
BE158540A BE831654A (fr) 1974-07-25 1975-07-23 Nouveaux derives de quinazoline et medicament les contenant

Country Status (7)

Country Link
AT (1) AT344178B (de)
BE (1) BE831654A (de)
CS (1) CS192549B2 (de)
ES (4) ES439690A1 (de)
HU (1) HU174961B (de)
PL (6) PL104615B1 (de)
SU (5) SU578874A3 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006135649A3 (en) * 2005-06-10 2007-02-15 Janssen Pharmaceutica Nv Aminoquinoline and aminoquinazoline kinase modulators

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006135649A3 (en) * 2005-06-10 2007-02-15 Janssen Pharmaceutica Nv Aminoquinoline and aminoquinazoline kinase modulators

Also Published As

Publication number Publication date
PL103789B1 (pl) 1979-07-31
AT344178B (de) 1978-07-10
PL103791B1 (pl) 1979-07-31
PL103798B1 (pl) 1979-07-31
ES455985A1 (es) 1978-06-16
HU174961B (hu) 1980-04-28
PL193423A1 (pl) 1978-04-24
SU613723A3 (ru) 1978-06-30
PL103797B1 (pl) 1979-07-31
PL193420A1 (pl) 1978-04-24
PL193422A1 (pl) 1978-06-05
SU858563A3 (ru) 1981-08-23
ES455986A1 (es) 1978-06-01
SU625606A3 (ru) 1978-09-25
ES455984A1 (es) 1978-06-01
PL99427B1 (pl) 1978-07-31
SU634671A3 (ru) 1978-11-25
ES439690A1 (es) 1977-07-01
SU578874A3 (ru) 1977-10-30
CS192549B2 (en) 1979-08-31
PL104615B1 (pl) 1979-08-31
ATA525275A (de) 1977-11-15
PL193419A1 (pl) 1978-04-24
PL193421A1 (pl) 1978-04-24

Similar Documents

Publication Publication Date Title
EP0506532B1 (de) Indolderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
EP0371876A1 (de) Isoxazole und Isoxazolin-Derivate mit Antikonvulsiva und pharmazeutische Zusammensetzungen, die sie enthalten
CH639974A5 (fr) Spiro-oxazolidine-diones.
EP0370901A1 (de) Zentralnervensystem wirksame Chromanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
FR2531707A1 (fr) Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
EP0040591A1 (de) Pyridoxin-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
EP0177392A1 (de) (Pyridyl-2)-1-piperazine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
EP0138721B1 (de) Benzensulfonyllactame, Verfahren zu ihrer Herstellung und ihre Anwendung als wirksame Bestandteile in pharmazeutischen Zusammensetzungen
EP0312432B1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
EP0109866B1 (de) Sulfonylharnstoff-Derivate, Verfahren zur Herstellung und pharmazeutische Zusammenstellungen die sie enthalten
FR2626175A1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
FR2526434A1 (fr) Nouveaux azepino-indoles, leur preparation et leur utilisation comme medicaments
CH634321A5 (en) trans-5-Aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles, process for their preparation and pharmaceutical composition containing them
EP0259206B1 (de) 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0000452B1 (de) 1,2,4-Oxadiazolderivate, ihre Herstellung und Verwendung als Arzneimittel
CA1082716A (fr) Procede de preparation de nouveaux derives de 5- thiazole methane amine
BE831654A (fr) Nouveaux derives de quinazoline et medicament les contenant
EP0076755A1 (de) Acylamino-4-aza-1-adamantane, Verfahren zu ihrer Herstellung und ihre Anwendung in der Therapeutik
EP0079411B1 (de) Indoloquinolizinderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung
FR2514003A1 (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
EP0406502B1 (de) Verfahren zur Herstellung von (-)2-(2-(2-Aminoethoxy)ethoxy)methyl)-4-(2,3-dichlorphenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridin, und Zwischenprodukt zu dessen Herstellung.
FR2543952A1 (fr) Composes hydrocarbones heterocycliques appartenant aux series indoliques et leur application pharmacologique
LU84278A1 (fr) Phenethylpiperidines antiarythmiques
FR2626177A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur utilisation comme medicaments

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER CORP.

Effective date: 19840723